Mosaic ImmunoEngineering (CPMV) Operating Expenses (2010 - 2026)

Mosaic ImmunoEngineering has reported Operating Expenses for 17 years, with the latest figure at $154802.0 in Q1 2026.

• On a quarterly basis, Operating Expenses fell 11.43% year-over-year to $154802.0 in Q1 2026; TTM through Mar 2026 was $596147.0, a 24.12% decrease from a year earlier, with the FY2025 full-year figure at $616119.0, down 29.96% from the prior year.
• Operating Expenses was $154802.0 for Q1 2026 at Mosaic ImmunoEngineering, up from $148133.0 in the prior quarter.
• The five-year high for Operating Expenses was $883726.0 in Q2 2022, with the low at $144358.0 in Q3 2025.
• Average Operating Expenses over 5 years is $333992.1, with a median of $274302.0 recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses sank 60.11% in 2023, then dropped 1.35% in 2025.
• Over 5 years, Operating Expenses stood at $497554.0 in 2022, then slumped by 44.61% to $275618.0 in 2023, then plunged by 45.52% to $150157.0 in 2024, then declined by 1.35% to $148133.0 in 2025, then climbed by 4.5% to $154802.0 in 2026.
• The last three Operating Expenses figures came in at $154802.0 (Q1 2026), $148133.0 (Q4 2025), and $144358.0 (Q3 2025), per Business Quant data.